あすか製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証1部 | 医薬品 | 4514/E00929 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/04/17 | 日証協 | 281,892株 | -0.95% | 16,000株 | -40.74% | 526,939株 | -1.42% | 5,800株 | -77.61% |
2015/04/10 | 日証協 | 284,592株 | -17.09% | 27,000株 | -29.86% | 534,539株 | -0.35% | 25,900株 | -94.14% |
2015/04/03 | 日証協 | 343,252株 | +338.09% | 38,496株 | -53.22% | 536,399株 | +350.76% | 441,733株 | +9999.99% |
2015/03/20 | 日証協 | 144,352株 | -17.96% | 60,896株 | +203.57% | 269,499株 | -8.86% | 3,100株 | -49.18% |
2015/03/13 | 日証協 | 175,952株 | +4.8% | 20,060株 | -45.33% | 295,699株 | +1.16% | 6,100株 | -81.49% |
2015/03/06 | 日証協 | 167,892株 | -0.83% | 36,696株 | +29.25% | 292,309株 | +6.62% | 32,960株 | +790.81% |
2015/02/27 | 日証協 | 169,292株 | -11.08% | 28,392株 | +14.95% | 274,149株 | -2.94% | 3,700株 | -64.44% |
2015/02/20 | 日証協 | 190,396株 | -24.25% | 24,700株 | -1.44% | 282,453株 | -3.57% | 10,404株 | -32.04% |
2015/02/13 | 日証協 | 251,356株 | -13.61% | 25,060株 | -86.69% | 292,909株 | -21.42% | 15,310株 | -92.36% |
2015/02/06 | 日証協 | 290,956株 | +7.5% | 188,260株 | +56.81% | 372,759株 | +20.42% | 200,467株 | +2699.82% |
2015/01/30 | 日証協 | 270,651株 | +26.47% | 120,055株 | +166.2% | 309,547株 | -25.05% | 7,160株 | -26.19% |
2015/01/23 | 日証協 | 213,996株 | -6.51% | 45,100株 | +146.46% | 413,032株 | -9.07% | 9,700株 | +40.58% |
2015/01/16 | 日証協 | 228,896株 | +2% | 18,299株 | -23.44% | 454,232株 | 0% | 6,900株 | -90.17% |
2015/01/09 | 日証協 | 224,397株 | -2.86% | 23,900株 | +236.62% | 454,232株 | +10.14% | 70,200株 | +602% |
2014/12/30 | 日証協 | 230,997株 | +0.39% | 7,100株 | -56.17% | 412,432株 | +0.12% | 10,000株 | +44.93% |
2014/12/26 | 日証協 | 230,097株 | +5.21% | 16,200株 | -69.49% | 411,932株 | +9.81% | 6,900株 | -97.52% |
2014/12/19 | 日証協 | 218,697株 | +73.85% | 53,100株 | -32.7% | 375,132株 | +224.7% | 278,600株 | +523.27% |
2014/12/12 | 日証協 | 125,797株 | +1.62% | 78,900株 | +56.24% | 115,532株 | +12.57% | 44,700株 | +136.51% |
2014/12/05 | 日証協 | 123,797株 | -3.13% | 50,500株 | +639.49% | 102,632株 | +5.66% | 18,900株 | -0.15% |
※株式分割は考慮していませんのでご注意ください。
Page Top